Respiratory Function clinical trials

Explore recruiting respiratory function clinical trials.

Recruiting respiratory function studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Respiratory Function trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Evaluation of the effect of para-sternal block on postoperative respiratory function after sternotomy cardiac surgery. Prospective, controlled, randomized, single-blind study with independent assessment of outcome

France

Therapeutic use (Phase IV) EU CTIS Study details

QUIDOSE. Randomized controlled trial testing the efficacy of hydroxychloroquine combined with low dose corticosteroid therapy in pulmonary sarcoidosis.

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Pulmonary function and sleep related disorders during cervical admission of intrathecal baclofen in spinal cord injury; a safety study

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A PET-MRI study of serotoninergic brainstem pathway in patients with Dravet Syndrome - DRAPETONINE

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Open label, long-term safety, tolerability, and efficacy study of GIVINOSTAT in all DMD patients who have been previously treated in one of the GIVINOSTAT studies.

Germany, Netherlands, Spain, France, Belgium, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

A PHASE II, SINGLE-CENTER, RANDOMIZED DOUBLE BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFECT OF THE COMBINED THERAPY OF EH-301 AND N-ACETYLCYSTEINE TOGETHER WITH RILUZOLE IN AMBULANT PATIENTS DIAGNOSED WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS)

Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Respiratory Function trials by city

Respiratory Function in Toronto Respiratory Function in Vancouver Respiratory Function in Montreal Respiratory Function in Calgary Respiratory Function in Edmonton Respiratory Function in Ottawa Respiratory Function in Winnipeg Respiratory Function in Quebec City Respiratory Function in Hamilton Respiratory Function in Kitchener Respiratory Function in London Respiratory Function in Halifax Respiratory Function in New York Respiratory Function in Los Angeles Respiratory Function in Chicago Respiratory Function in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease